Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
WOLVES HAND, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 9%, Raises Record High Profit Forecast
194A WOLVES HAND Co.,Ltd. 【J-GAAP】
Earnings ReportWOLVES HAND Co.,Ltd. <194A> [TSE Growth] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending June 2026 (July to December) expanded 0.45 billion yen, an increase 45.2% compared to the same period last year.
In addition, the full-year forecast for consolidated ordinary profit has been revised upward 9.2%, from the previous forecast of 1.00 billion yen to 1.10 billion yen (compared to 0.90 billion yen in the previous period), increasing the growth rate from 10.9% to 21.1%, further surpassing the previous forecast of record-high profits for six consecutive terms.
Based on the first-half performance announced by the company and the full-year plan, our calculation indicates that the consolidated ordinary profit for the January to June period (second half) is expected to grow 8.6% from the same period last year, reaching 0.64 billion yen.
In the most recent three-month period, from October to December (2Q), the consolidated ordinary profit grew 20.7% from the same period last year, reaching 0.21 billion yen. The operating profit margin rose from 13.9% in the same period last year to 14.2%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2024 | 2,512 | 314 | 312 | 177 | 23.8 | 34.4 | Feb 14, 2025 | J-GAAP |
| Jul - Dec, 2025 | 2,798 | 443 | 453 | 300 | 40.1 | 41.2 | Feb 13, 2026 | J-GAAP |
| YoY | +11.4% | +41.1% | +45.2% | +69.5% | +68.5% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Dec, 2025 Guidance | ー | ー | ー | ー | - | 0 | Aug 15, 2025 | J-GAAP |
| Jul - Dec, 2025 Results | 2,798 | 443 | 453 | 300 | 40.1 | 0 | Feb 13, 2026 | J-GAAP |
| Revision Rate | - | - | - | - | - |
Guidance Update
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2026 Prev | 5,753 | 995 | 1,007 | 643 | 85.4 | 0 | Aug 15, 2025 | J-GAAP |
| Jun, 2026 New | 6,150 | 1,100 | 1,100 | 840 | 111.5 | 0 | Feb 13, 2026 | J-GAAP |
| Revision Rate | +6.9% | +10.6% | +9.2% | +30.6% | +30.6% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 2,951 | 595 | 596 | 416 | 55.7 | 0 | Aug 15, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | 3,352 | 657 | 647 | 540 | 71.7 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | +13.6% | +10.4% | +8.6% | +29.8% | +28.8% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2024 | 4,990 | 827 | 800 | 558 | 75.2 | 0 | Aug 9, 2024 | J-GAAP |
| Jun, 2025 | 5,463 | 909 | 908 | 593 | 79.3 | 0 | Aug 15, 2025 | J-GAAP |
| Jun, 2026 Guidance | 6,150 | 1,100 | 1,100 | 840 | 111.5 | 0 | Feb 13, 2026 | J-GAAP |
| YoY | +12.6% | +21.0% | +21.1% | +41.7% | +40.6% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 1,261 | 175 | 174 | 110 | 14.8 | 13.9 | Feb 14, 2025 | J-GAAP |
| Jan - Mar, 2025 | 1,291 | 155 | 197 | 124 | 16.6 | 12.0 | May 15, 2025 | J-GAAP |
| Apr - Jun, 2025 | 1,660 | 440 | 399 | 292 | 39.1 | 26.5 | Aug 15, 2025 | J-GAAP |
| Jul - Sep, 2025 | 1,365 | 239 | 243 | 165 | 22.1 | 17.5 | Nov 13, 2025 | J-GAAP |
| Oct - Dec, 2025 | 1,433 | 204 | 210 | 135 | 18.0 | 14.2 | Feb 13, 2026 | J-GAAP |
| YoY | +13.6% | +16.6% | +20.7% | +22.7% | +22.1% |
Related Articles
HOSHIZAKI, 5% Increase in Ordinary Profit, Record High for The First Time in Two Years
Nomura Micro Science, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 38%, Oct-Dec Ordinary Profit Decreases by 34%
MICRONICS JAPAN, 40% Increase in Ordinary Profit for the Last Fiscal Year, Current period performance is undisclosed., Increased Previous Year's Dividend by 23 Yen
D.I.System, Oct-Dec (1Q) Ordinary Profit Decreases by 48%
CK SAN-ETSU, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 47%
ISEKI &, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 19% Increase in The Current Fiscal Year, Dividend Raised by 5 Yen
Sun* Inc, 90% Increase in Ordinary Profit for The Current Fiscal Year
TRE HOLDINGS, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 12%
FRUTA FRUTA, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 6%, Oct-Dec Ordinary Profit Turns to Loss
RaQualia Pharma, Last Fiscal Year Ends in Surprise Net Income, The Current Fiscal Year's Net Income Turns to Loss